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Background: Healthcare costs are increasing rapidly and at an unsustainable rate in many countries, and inpatient
hospitalizations are a significant driver of these costs. Clinical decision support (CDS) represents a promising
approach to not only improve care but to reduce costs in the inpatient setting. The purpose of this study was to
systematically review trials of CDS interventions with the potential to reduce inpatient costs, so as to identify
promising interventions for more widespread implementation and to inform future research in this area.
Methods: To identify relevant studies, MEDLINE was searched up to July 2013. CDS intervention studies with the
potential to reduce inpatient healthcare costs were identified through titles and abstracts, and full text articles were
reviewed to make a final determination on inclusion. Relevant characteristics of the studies were extracted and
summarized.
Results: Following a screening of 7,663 articles, 78 manuscripts were included. 78.2% of studies were controlled
before-after studies, and 15.4% were randomized controlled trials. 53.8% of the studies were focused on pharmacotherapy.
The majority of manuscripts were published during or after 2008. 70.5% of the studies resulted in statistically and
clinically significant improvements in an explicit financial measure or a proxy financial measure. Only 12.8% of the
studies directly measured the financial impact of an intervention, whereas the financial impact was inferred in the
remainder of studies. Data on cost effectiveness was available for only one study.
Conclusions: Significantly more research is required on the impact of clinical decision support on inpatient costs. In
particular, there is a remarkable gap in the availability of cost effectiveness studies required by policy makers and
decision makers in healthcare systems.
Keywords: Clinical decision support, Clinical costs, Cost effectiveness, Hospital care, Emergency medical care,
Health information technologyBackground
Healthcare costs are increasing rapidly and at an unsus-
tainable rate in many countries. In the United States, in-
patient care is the single largest contributor to national
health expenditures, accounting for 31.5% of $2.7 trillion
dollars of health expenditures in 2011 [1]. As such, in-
patient care is a significant driver of increased health
spending. In 2011, the annual spending on hospital care in
the U.S. grew 4.3% as compared to 3.9% growth in overall
health expenditures [1]. Contributing to the importance of* Correspondence: christopher.fillmore@utah.edu
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reproduction in any medium, provided the oraddressing inpatient costs is the fact that reducing these
costs has the potential to financially benefit inpatient
healthcare organizations regardless of reimbursement
models. Traditional episode-of-care payment systems
(for example, Medicare's inpatient prospective payment
system), bundled payments systems, and comprehensive
payment systems (embodied in accountable care organiza-
tions) are all examples of reimbursement models under
which healthcare organizations stand to benefit from re-
ducing inpatient costs [2].
Clinical decision support (CDS) represents a promising
approach to both improving outcomes and decreasing
costs [3]. Several past systematic reviews have examinedl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Fillmore et al. BMC Medical Informatics and Decision Making 2013, 13:135 Page 2 of 9
http://www.biomedcentral.com/1472-6947/13/135outcomes related to clinical decision support systems in
the inpatient setting, but few have focused on the impact
of CDS on inpatient costs specifically [4-9]. One review
published in 2006 evaluated cost as an outcome [10].
However, that review was focused on health information
technology (IT) in general rather than CDS specifically.
Moreover, it only included studies published through
January 2004. A second, more recent review on CDS in-
cluded cost outcomes but was limited to studies with a
randomized trial design [11]. The design and timing of
these two reviews potentially excluded relevant CDS inter-
vention trials. In particular, non-randomized research de-
signs are commonly used to evaluate CDS interventions.
Given the importance of limiting the growth of in-
patient costs and the potential benefit of CDS, we sought
to (i) inclusively identify promising interventions that
could serve as models for more widespread implementa-
tion and to (ii) identify gaps in the literature warranting
further research. As such, we systematically reviewed
both randomized and non-randomized trials of CDS sys-




Using a search strategy adapted from a previous systematic
review [7], we searched MEDLINE through July 18, 2013.
The latest search was performed on that date. We used a
combination of the following search terms: decision sup-
port systems, clinical; decision-making, computer-assisted;
computerized decision support; reminder systems; guideline
adherence; and medical informatics. Details of the search
strategy are available in Appendix I. Search results were
limited to human subjects and the English language.
Inclusion and exclusion criteria
We defined a CDS system as a system designed to directly
aid in clinical decision making, in which characteristics of
individual patients are matched to a knowledge base for
the purpose of presenting patient-specific assessments or
recommendations to clinicians [4]. Inclusion criteria were
as follows: peer-reviewed primary manuscript; clinical trial
of a CDS system in an inpatient or emergency department
(ED) setting; and use of either cost or a proxy measure for
cost (e.g., length of stay; see Data Extraction section for full
list) as an outcome metric. Of note, we opted to include
studies in an ED setting, as these costs often become part
of inpatient costs because many ED patients are admitted
to the hospital. Exclusion criteria were as follows: non-
English manuscript; or use of CDS in the control group.
Study selection
Titles and abstracts from retrieved references were eva-
luated by a single reviewer to determine potentialinclusion eligibility. The full texts of studies that appeared
to be potentially eligible were then evaluated by the same
reviewer. Final inclusion determinations were made using
the full texts. In cases where a study’s inclusion status was
unclear upon review by the primary reviewer, the authors
jointly reviewed the study and made a consensus decision.
Data extraction
Data extraction was performed by a single reviewer using
a standardized form. Any issues involving uncertainty
were resolved through author consensus. For each article
that met inclusion criteria, data were extracted on setting,
trial design, intervention, and trial results. Setting was
assigned as one of three categories: ED, ICU, or hospital.
A hospital setting typically included inpatient wards, but
could also include a combination of wards, ED, ICU, or
surgical settings. Trial design was assigned based on cat-
egories defined by the Cochrane Effective Practice and
Organization of Care Group [12]. Design categories in-
cluded randomized controlled trials (RCTs), non-
randomized controlled trials (NRCTs), controlled before-
after studies (CBA), and interrupted-time-series studies
(ITSs).
Abstracted trial results included outcomes with poten-
tial cost saving implications, whether costs were directly
measured, whether there was a statistically and clinically
significant improvement in cost or in a proxy measure,
and whether the study could be considered a cost effec-
tiveness study. Specifically, measures with potential cost
saving implications consisted of direct cost measures or
other proxy measures with cost ramifications. Proxy cost
measures included length of stay, readmission rates, re-
source utilization metrics (e.g., imaging studies), adverse
events, and process measures correlated with adverse
events. A change in a cost or proxy measure was decided
a priori to be the primary outcome measure. Clinical sig-
nificance of results was determined by author consensus.
To be considered a cost effectiveness study, the study
must have accounted at least for the personnel costs in-
cluded in developing and deploying the intervention. For
commercial CDS systems, at least the cost of licensing
the software must also have been considered.
Data analysis
Extracted data were analyzed and presented in table form
and narrative summary. Additionally, significant themes,
trends, and patterns were noted and discussed. To better
understand the potential relationship between study out-
comes and potential explanatory factors, Fisher’s exact test
of independence was conducted with the independent
variable being a statistically and clinically significant im-
provement in an actual or proxy cost measure. One of the
potential explanatory variables examined was study qua-
lity, with CBA trials and NRCTs conducted at single sites
Fillmore et al. BMC Medical Informatics and Decision Making 2013, 13:135 Page 3 of 9
http://www.biomedcentral.com/1472-6947/13/135distinguished from studies that utilized more rigorous
study designs. Other potential explanatory variables exa-
mined included study setting and clinical domain. For the
purposes of this analysis, clinical domains with two or
fewer studies were combined into a single category. A
p-value of < 0.05 was considered statistically significant.
Results and discussion
The literature search returned a total of 7,663 unique re-
ferences. 7,500 references were excluded after screening of
titles and abstracts. We reviewed 163 full-text articles, of
which 78 [13-90] met criteria for inclusion in the review
(see Figure 1). Characteristics of these studies are summa-
rized in Additional file 1: Table S1.
Study timing
A majority (52.6%) of studies were published during or after
2008 [14,15,18-20,25,26,29,32-34,38-40,43-47,49,50,55-61,
65-67,70,74-76,78,81,82,85,86,90]. The earliest includedFigure 1 Summary of literature search and selection.study was published in 1989 [54]. This high concentra-
tion of studies published between 2008 and 2013 repre-
sents large recent growth in the evaluation of inpatient
CDS systems and is likely consistent with increasing
adoption of health IT generally.
Study settings
A majority of the studies (55.1%) took place in a general
hospital setting ([14-17,19,24-26,28,30,32,33,37,41-43,46,
48-50,52-56,60-62,64,66,67,69-72,74,76-78,80,85,87,90].
29.5% of the studies occurred in an ICU setting
[18,23,31,34-36,39,40,44,47,51,57-59,63,65,68,73,79,82,86,
88,89], and 15.4% took place in an ED setting [13,
20-22,27,29,38,45,75,81,83,84].
Study designs
A large proportion (84.6%) [13-18,20-27,29,30,32-37,39-52,
54-58,60,61,64-70,72-78,82-90] of the studies were quasi-
experimental trials, which can be defined as studies that
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mization [91]. Overall, the most common design used in
the studies was the controlled before-after design, wherein
researchers used historical controls prior to the im-
plementation of an intervention. Of the 78 studies, 61
(78.2%) were some form of controlled before-after study
[13-18,20-27,29,30,32-37,39-51,54,55,57,60,61,64,65,68-70,
72-78,82-90]. Only 12 (15.4%) of the studies were rando-
mized controlled trials (RCTs) [19,28,31,38,53,59,62,63,
71,79-81]. The remaining five studies were interrupted-
time-series studies [56,58] and non-randomized controlled
trials [52,66,67].
The frequent use of quasi-experimental designs in me-
dical informatics evaluations has been noted previously
[91,92], and the results of this review are consistent. Given
the overwhelming prevalence of quasi-experimental de-
signs, reviews of CDS systems that only include RCTs are
bound to exclude a large portion of the published litera-
ture. With respect to this systematic review, a deliberate
decision was made to include quasi-experimental studies,
as one of the primary goals of this study was to inclusively
identify CDS interventions that have the potential for re-
ducing inpatient costs. At the same time, the inclusion of
quasi-experimental study designs certainly resulted in the
inclusion of studies that are more subject to bias than
RCTs.
Clinical focus
The most common clinical focus targeted by CDS systems
in the review was pharmacotherapy, with 53.8% of studies
focused on this area [16-18,20,23,24,26,35,37,39,40,42,
43,45,47,48,50,51,54,57-62,64,65,67-69,71-74,76-79,85,88-90].
Of the studies focused on pharmacotherapy, the most com-
mon areas of specific focus were nephrotoxic drugs (23.8%)
[24,41,60,69,76-78,85,90], antibiotics (21.4%) [20,23,26,35,
54,62,68,71,88], and insulin management (14.3%) [39,40,57,
59,65,79].
The second most common area of clinical focus
was venous thromboembolism prophylaxis, which ac-
counted for 9% of studies in the review [28,30,43,46,
53,55,87]. Examples of other clinical areas addressed
included blood transfusion management [14,36,80],
ventilation management [31,34,63], and radiology uti-
lization [22,29,75].
The significant focus on pharmacotherapy within the
included studies may reflect the importance of drug se-
lection within computerized provider order entry (CPOE)
systems, which are foundational to CDS in many inpatient
settings. 50% [14,16,17,19,22-26,28-30,35-37,41-43,45,46,
48,50,56,58,60,61,64,66-68,72,73,75,76,80,85,87,89,90] of
the studies overall involved CDS in the context of CPOE,
of which 61.5% [16,17,23,24,26,35,37,41,42,45,48,50,
58,60,61,64,67,68,72,73,76,85,89,90] were focused on
pharmacotherapy.Cost effectiveness
Only one of the 78 studies (1.3%) was considered to be a
cost effectiveness study [33]. This study evaluated the use
of a well-known diagnostic decision support system,
DXplain, with residents in a teaching hospital. The au-
thors reported that access to DXplain had been provided
at no charge for the purposes of the study, but that an
annual license would have cost their organization $4,000-
$6,000 per year [33]. It is telling that the only study to
address cost effectiveness in this review concerned a sim-
ple license to a stand-alone, diagnostic CDS system. The
majority of the studies in this review dealt with more com-
prehensive, integrated systems either purchased through
vendors or developed locally. Under those circumstances,
providing information about cost of development, imple-
mentation, or licensing fees is presumably more difficult.
However, the near complete lack of this type of infor-
mation is concerning given the need for such cost-
effectiveness information by public policy developers and
decision makers within healthcare organizations.
Direct measurement of cost
10 (12.8%) studies in the review directly measured costs
[20,24,33,35-37,62,64,68,71]. Eight of these studies focused
on pharmacotherapy [20,24,35,37,62,64,68,71], while the
other two addressed management of blood transfusion
[36] and general medical diagnosis [33]. These studies in-
cluded two RCTs [62,71], with the remainder of studies
having a quasi-experimental design. Of these studies, five
reported a statistically and clinically significant improve-
ment in a cost measure [33,35,36,62,71]. Except in one
case as outlined, the cost involved in implementing these
interventions was not studied. Because investments in
CDS are like any other business investment, having only
one side of the financial equation (cost impact) is insuf-
ficient for making public policy and business decisions.
Use of proxy cost measures
87.1% of the studies in the review solely reported proxy
measures as indicators of impact on cost [13-19,21-23,
25-32,34,38-61,63,65-67,69,70,72-90]. The most commonly
used type of proxy measure in this group was process mea-
sures that were associated with adverse events. Of the stud-
ies that solely used proxy measures, 52.9% reported this
type of measure [15-17,22,25,26,28,30,32,34,41-43,46,50-54,
60,61,66,67,70,73,74,76-78,80,85-87,89,90]. Examples of
other proxy measures reported by these studies included
rates of adverse events (reported by 39.7% of studies
[16-19,23,25,26,39,40,43,45-47,53-55,57-59,63,65,67,69,72,
73,79,90]), length of stay (reported by 22.1% of studies
[15,19,31,38,44,45,47,49,57,63,66,67,72,81,82]), resource
utilization metrics (reported by 16.2% of studies [13,14,
29,38,48,56,75,81,82,86,88]) and patient charges (reported
by 5.9% of studies [21,27,83,84]).















No 18 8 (44%) 10 (56%)
Yes 60 15 (25%) 45 (75%)
Setting 0.17
ED 12 5 (42%) 7 (58%)
Hospital 43 9 (21%) 34 (79%)
ICU 23 9 (39%) 14 (61%)
Domain 0.04
Pharmacotherapy 42 12 (29%) 30 (71%)
Radiology 3 1 (33%) 2 (67%)
Transfusion 3 0 3 (100%)
VTE Prophylaxsis 7 0 7 (100%)
Ventilation
management
3 3 (100%) 0
Other 20 7 (35%) 13 (65%)
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directly measured an intervention’s impact on cost. There-
fore, in the majority of cases we were left to infer a pos-
sible cost savings from non-financial proxy measures.
Doing so has some inherent limitations. For example,
five studies reported patient charges as an outcome
[21,27,33,83,84]. This is not a direct measure of cost, and
it can be unclear as to how charges actually relate to cost
[93]. We assumed that an institution’s costs were at least
proportional to what it charged a patient. However, given
that we did not know the actual relationship between
costs and charges at any given institution, this assumption
suffered from an element of uncertainty.
A second limitation of using proxy measures is illus-
trated by the conflict of explicit cost measures and proxy
measures within the same study. For example, two studies
reported no differences in actual measured costs but re-
ported decreases in length of stay [24,64]. For this review,
we considered length of stay a reasonable proxy measure
for cost. But in these two instances, shorter lengths of stay
did not coincide with actual decreased costs. The reverse
of this situation was present in two studies, where directly
measured costs decreased, but no difference in length of
stay was detected [33,62]. It is notable that of the ten stu-
dies in the review that directly measured costs, four
demonstrated discrepancies between explicit cost mea-
sures and available proxy cost measures.
A third limitation of using proxy measures is related
to the inconsistent relationship between process mea-
sures correlated with adverse events and the actual rates
of those adverse events. We considered measures of
adverse events an appropriate proxy measure for cost
given the potential for these events to necessitate the
utilization of additional resources. We went a step fur-
ther and included process measures correlated with ad-
verse events as proxy measures as well. For example,
one study in the review reported the rate of compliance
with venous thromboembolism prophylaxis guidelines
(a process measure correlated with an adverse event)
[30]. Alternatively, another study reported the actual in-
cidence of venous thromboembolism (a measure of an
adverse event) [53]. For this review, we made the as-
sumption that an improvement in a process measure as-
sociated with an adverse event would be associated with
an improvement in the incidence of that adverse event.
Decreased incidence of an adverse event, in turn, would
be associated with cost savings. However, in one study,
process measures correlated with an adverse event were
significantly improved, but there was no improvement
in the incidence of the actual adverse event [26]. More
perplexingly, another study reported improvements in a
process measure, no improvement in the correlated ad-
verse event, and a significant improvement in length of
stay [67].Impact on cost/proxy measures
55 (70.5%) of the studies reported a statistically and clini-
cally significant improvement in a cost or proxy measure
[13-18,21-23,25,26,28,30,32,33,35,36,38-43,45-50,53-57,
59-62,65-67,69,71,73-75,77,78,80,82,84,86-88,90]. However,
when considered in the context of the lack of direct cost
measurements, the limitations of proxy cost measures,
and the prevalence of quasi-experimental designs, it is dif-
ficult to know what level of confidence to place in that
finding. On the face of it, CDS does appear to be a pro-
mising intervention for reducing inpatient costs. However,
further research is clearly needed in order to more con-
cretely characterize the benefits that have been achieved
and that might be achieved in the future.
Relationship between primary study outcome and
potential explanatory factors
Table 1 provides the results of Fisher’s exact tests of in-
dependence between the primary study outcome and
potential explanatory factors. There was a trend towards
single-site CBA and NRCT studies having more positive
outcomes than more rigorous studies (75% vs. 56%,
p = 0.14), which was an expected finding given the bias
known in the literature for poorer-quality studies more
frequently showing positive outcomes. Study setting did
not appear to be significantly associated with study out-
comes, whereas clinical domain did appear to have a
significant relationship with study outcomes (p = 0.04).
In particular, all of the seven studies on VTE prophy-
laxis and all of the three studies on transfusion had
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interpreting the implications of these statistical analyses,
as the interventions were heterogeneous in nature, and as
the proxy outcome measures utilized in these analyses had
several important limitations as discussed earlier. The
primary finding from our study remains that additional re-
search is required on the true cost implications of CDS in
the inpatient setting.
Models for more widespread implementation
One of the aims of this study was to identify interventions
that were promising for more widespread implementation.
As noted, a large proportion of the CDS interventions
found in this review are related to pharmacotherapy
within the context of CPOE. As organizations continue to
adopt or expand CPOE systems with integrated CDS, a
potentially promising area to focus on is the management
of antibiotics, as three of the five studies that directly
measured costs and demonstrated improvement in cost
metrics [35,62,71] were focused specifically on the ma-
nagement of antibiotics. Another promising area for imple-
mentation is venous thromboembolism prophylaxis, as all
seven of the studies with this focus demonstrated improve-
ments in the outcomes of interest [28,30,43,46,53,55,87].
Limitations
Our study is potentially limited by the use of only one
database, MEDLINE, for our search. As a result, there was
a risk to exclude relevant articles. However, in a pre-
vious systematic review of CDS interventions [7], which
searched MEDLINE, CINAHL, and the Cochrane Central
Register of Controlled Trials, all 88 of the studies included
in the final study sample were indexed and available in
MEDLINE. Therefore, we believe that this risk is limited.
A further potential limitation of our study is the use of a
single reviewer to perform study selection and data extrac-
tion. However, any issues involving uncertainty were re-
solved through author consensus to manage this risk.
Conclusions
Health IT, and CDS in particular, has been touted for
many years as a highly promising strategy for improving
clinical care and “bending the cost curve” [94,95]. How-
ever, more recent analyses have found that health IT sys-
tems such as EHR systems are not having the anticipated
benefits in cost reduction [96,97]. This study adds to these
concerns that the potential benefits of health IT and CDS
are not well grounded in empirical evidence, with only ten
studies directly measuring costs and only one actually
measuring cost-effectiveness of CDS for inpatient cost
reduction.
As healthcare organizations continue to rapidly adopt
health IT, leadership within those organizations must de-
cide how to best use limited resources. Presumably, thepotential cost savings associated with intervention candi-
dates is a major factor in making those decisions. How-
ever, as a discipline, informatics does not appear to be
meeting the needs of these healthcare decision makers
with regard to CDS, as we have not been providing suffi-
cient, rigorous data related to the cost benefits of CDS
interventions in the inpatient setting. Further research
with specific attention to cost implications of CDS sys-
tems in the inpatient setting is clearly needed.
Appendix I
Search strategy details
1. exp Decision Support Systems, Clinical/
2. Decision Making, Computer-Assisted/
3. "computerized decision support".mp.
4. exp Reminder Systems/
5. exp Guideline Adherence/
6. exp Medical Informatics/
7. 5 and 6
8. 1 or 2 or 3 or 4 or 7
9. limit 8 to (english language and humans)
Additional file
Additional file 1: Table S1. Summary of study characteristics.
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